BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study
Alignment of TMB measured on clinical samples: Phase IIB of the Friends of Cancer Research TMB Harmonization Project
Different genomic mutations signatures are associated to specific PD-L1/TMB states on lung cancer with potential value for patients screening for immunotherapy
A comprehensive genomic profiling approach to interrogate hematologic malignancies
Analytical development of the RaDaRTM assay, a highly sensitive and specific assay for the monitoring of minimal residual disease
Distinguishing dendritic cell subtypes in the tumor microenvironment using MultiOmyxTM
Exploitation of Treatment Induced Tumor Lysis to Enhance Sensitivity of ctDNA Analysis: A First-In-Human Pilot Study